MET and gastric cancer: At present, the therapeutic targets of gastric cancer mainly include HER-2, EGFR, PI3K, mTOR and c-Met, etc., and targeted drugs targeting these receptors and kinases have achieved certain results in the clinical application of gastric cancer treatment (73).